Micafungin Injection, Powder, Lyophilized, For Solution
Product Images NDC 67184-0589
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Micafungin (NDC 67184-0589). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Qilu Pharmaceutical Co., Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Container Label For Strength 50 mg/vial (Image 02)
This is a description of Micafungin for Injection, USP. Each vial contains 50 mg micafungin equivalent to 50.86 mg micafungin sodium, manufactured and marketed by QILU Pharmaceutical (Hainan) Co., Ltd. The reconstituted solution contains 10 mg micafungin per mL. It is recommended for intravenous infusion only, with instructions for reconstitution and dilution provided in the package insert. The product should be stored at 20°C to 25°C (68°F to 77°F) with excursions between 15°C to 30°C (59°F to 86°F). It is preservative-free and should be protected from light. It is a single-dose vial that should be discarded if unused.*
Container Label For Strength 100 mg/vial (Image 03)
This is a product description for Micafungin for Injection, USP, with each vial containing 100 mg micafungin sodium. The manufacturer is QILU Pharmaceutical, located in Haikou, China. Instructions for dosage, reconstitution, and dilution are available in the package insert. The product is to be stored at 20°C to 25°C (68°F to 77°F) with excursions allowed between 15°C to 30°C (59°F to 86°F). After reconstitution, each mL contains 20 mg micafungin. It is preservative-free and intended for intravenous infusion only. The product should be protected from light and is a single-dose vial. Unused portions should be discarded, and the product is a sterile, pharmaceutical item.*
Carton Labeling Of Single Vial For Strength 50 mg/vial (Image 04)
This text appears to be a description for a medication named Micafungin for Injection, USP. The medication is available in vials containing 50 mg of Micafungin sodium equivalent. The product is sterile and non-pyrogenic and requires reconstitution with sodium chloride injection or Dextrose Injection. The storage recommendation is between 20°C to 25°C. The medication is manufactured and marketed by Qilu Pharmaceutical. The information provided includes details about dosages, pH adjustments, and the proper method of reconstitution before administration.*
Carton Labeling Of Single Vial For Strength 100 mg/vial (Image 05)
Carton Labeling Of Ten Vials For Strength 50 mg/vial (Image 06)
Carton Labeling Of Ten Vials For Strength 100 mg/vial (Image 07)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.